Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 23-24/2020

20.05.2020 | review article

Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator

Different viewpoints around the world

verfasst von: M.D. Mona Cooper, M.D. Theresa Berent, Prim. Univ. Prof. Dr. Johann Auer, Prim. PD Dr. Robert Berent

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

The use of implantable cardioverter defibrillators (ICD) has been shown to improve survival in patients at risk of sudden cardiac death; however, due to the continuous risk of sudden loss of consciousness during arrhythmia or ICD intervention, they pose a potential risk to other road users while driving. A large number of opinions and recommendations from authorities and medical societies all over the world exist regarding driving restrictions after ICD implantation. This analysis provides an overview of the recommendations on driving restrictions from several countries. Furthermore, the use of the wearable and the subcutaneous ICD are taken into account.
Literatur
1.
Zurück zum Zitat Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–867. PubMed Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–867. PubMed
2.
Zurück zum Zitat Vijgen J, Botto G, Camm J, Hoijer CJ, Jung W, Le Heuzey JY, et al. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Eur J Cardiovasc Nurs. 2010;9:3–14. PubMed Vijgen J, Botto G, Camm J, Hoijer CJ, Jung W, Le Heuzey JY, et al. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Eur J Cardiovasc Nurs. 2010;9:3–14. PubMed
3.
Zurück zum Zitat Raatikainen MJP, Arnar DO, Zeppenfeld K, Merino JL, Levya F, Hindriks G, et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace. 2015;17:i1–75. PubMed Raatikainen MJP, Arnar DO, Zeppenfeld K, Merino JL, Levya F, Hindriks G, et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace. 2015;17:i1–75. PubMed
4.
Zurück zum Zitat Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10(4):e59–65. PubMed Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10(4):e59–65. PubMed
5.
Zurück zum Zitat -. Assessment of the cardiac patient for fitness to drive. Can J Cardiol. 1992;8:406–19. PubMed -. Assessment of the cardiac patient for fitness to drive. Can J Cardiol. 1992;8:406–19. PubMed
6.
Zurück zum Zitat -. Assessment of the cardiac patient for fitness to drive: 1996 update. Can J Cardiol. 1996;12:1164–82. PubMed -. Assessment of the cardiac patient for fitness to drive: 1996 update. Can J Cardiol. 1996;12:1164–82. PubMed
7.
Zurück zum Zitat Jung W, Luderitz B. Driving and the implantable cardioverter defibrillator. Study Group on ICD and Driving. Lancet. 1996;348:687–8. PubMed Jung W, Luderitz B. Driving and the implantable cardioverter defibrillator. Study Group on ICD and Driving. Lancet. 1996;348:687–8. PubMed
8.
Zurück zum Zitat Jung W, Anderson M, Camm A, Jordaens L, Petch M, Rosenqvist M. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J. 1997;18:1210–9. PubMed Jung W, Anderson M, Camm A, Jordaens L, Petch M, Rosenqvist M. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J. 1997;18:1210–9. PubMed
9.
Zurück zum Zitat Petch M. Driving and heart disease. Eur Heart J. 1998;19:1165–77. PubMed Petch M. Driving and heart disease. Eur Heart J. 1998;19:1165–77. PubMed
10.
Zurück zum Zitat Simpson C, Ross D, Dorian P. CCS Consensus Conference 2003: Assessment of the cardiac patient for fitness to drive and fly—executive summary primary panel assessment of the cardiac patient for fitness to drive. Can J Cardiol. 2004;20(13):1313–23. Simpson C, Ross D, Dorian P. CCS Consensus Conference 2003: Assessment of the cardiac patient for fitness to drive and fly—executive summary primary panel assessment of the cardiac patient for fitness to drive. Can J Cardiol. 2004;20(13):1313–23.
11.
Zurück zum Zitat Epstein AE, Baessler CA, Curtis AB, Estes NAM, Gersh BJ, Grubb B, et al. Addendum to personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scient.statem. from the Am. Heart Ass. and the North Am. Soc. of Pacing and Electrophysi. Circulation. 2007;115(9):1170–6. PubMed Epstein AE, Baessler CA, Curtis AB, Estes NAM, Gersh BJ, Grubb B, et al. Addendum to personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scient.statem. from the Am. Heart Ass. and the North Am. Soc. of Pacing and Electrophysi. Circulation. 2007;115(9):1170–6. PubMed
12.
Zurück zum Zitat Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing. Circulation. 1996;94(5):1147–66. PubMed Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing. Circulation. 1996;94(5):1147–66. PubMed
13.
Zurück zum Zitat Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation. 2002;106(14):1800–5. PubMed Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation. 2002;106(14):1800–5. PubMed
14.
Zurück zum Zitat Taggart P, Gibbons D, Somerville W. Some effects of motor-car driving on the normal and abnormal heart. Br Med J. 1969;4(5676):130–4. PubMedPubMedCentral Taggart P, Gibbons D, Somerville W. Some effects of motor-car driving on the normal and abnormal heart. Br Med J. 1969;4(5676):130–4. PubMedPubMedCentral
16.
Zurück zum Zitat Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ, et al. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med. 1991;115(12):942–5. PubMed Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ, et al. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med. 1991;115(12):942–5. PubMed
17.
Zurück zum Zitat Bänsch D, Brunn J, Castrucci M, Weber M, Gietzen F, Borggrefe M, et al. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol. 1998;31(3):608–15. PubMed Bänsch D, Brunn J, Castrucci M, Weber M, Gietzen F, Borggrefe M, et al. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol. 1998;31(3):608–15. PubMed
18.
Zurück zum Zitat Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: Implications for antiarrhythmic therapy and driving restrictions. J Am Coll Cardiol. 2001;37(7):1910–5. PubMed Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: Implications for antiarrhythmic therapy and driving restrictions. J Am Coll Cardiol. 2001;37(7):1910–5. PubMed
19.
Zurück zum Zitat Trappe HJ, Wenzlaff P, Grellman G. Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period. J Interv Card Electrophysiol. 1998;2(2):193–201. PubMed Trappe HJ, Wenzlaff P, Grellman G. Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period. J Interv Card Electrophysiol. 1998;2(2):193–201. PubMed
20.
Zurück zum Zitat Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, et al. Analysis of implantable cardioverter defibrillator therapy in the antiarrhythmics versus implantable defibrillators (AVID) trial. J Cardiovasc Electrophysiol. 2003;14(9):940–8. PubMed Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, et al. Analysis of implantable cardioverter defibrillator therapy in the antiarrhythmics versus implantable defibrillators (AVID) trial. J Cardiovasc Electrophysiol. 2003;14(9):940–8. PubMed
21.
Zurück zum Zitat Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Europace. 2014;16(2):227–34. PubMed Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Europace. 2014;16(2):227–34. PubMed
22.
Zurück zum Zitat Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(1):164–70. PubMed Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(1):164–70. PubMed
23.
Zurück zum Zitat Lampert R. Managing with pacemakers and Implantable cardioverter defibrillators. Circulation. 2013;128(14):1576–85. PubMed Lampert R. Managing with pacemakers and Implantable cardioverter defibrillators. Circulation. 2013;128(14):1576–85. PubMed
24.
Zurück zum Zitat Tan VH, Ritchie D, Maxey C, Sheldon R. Prospective assessment of the risk of vasovagal syncope during driving. JACC Clin Electrophysiol. 2016;2(2):203–8. PubMed Tan VH, Ritchie D, Maxey C, Sheldon R. Prospective assessment of the risk of vasovagal syncope during driving. JACC Clin Electrophysiol. 2016;2(2):203–8. PubMed
25.
Zurück zum Zitat Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, et al. Heart failure and the risk of shocks in patients with Implantable cardioverter defibrillators: results from triggers of ventricular arrhythmias (TOVA) study. Circulation. 2004;109(11):1386–91. PubMed Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, et al. Heart failure and the risk of shocks in patients with Implantable cardioverter defibrillators: results from triggers of ventricular arrhythmias (TOVA) study. Circulation. 2004;109(11):1386–91. PubMed
26.
Zurück zum Zitat Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, et al. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. JAMA. 1994;271(17):1335.9. PubMed Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, et al. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. JAMA. 1994;271(17):1335.9. PubMed
28.
Zurück zum Zitat Driver & Vehicle Licensing Agency U. Assessing fitness to drive—a guide for medical professionals. 2018. pp. 1–142. Driver & Vehicle Licensing Agency U. Assessing fitness to drive—a guide for medical professionals. 2018. pp. 1–142.
29.
Zurück zum Zitat Abello M, Merino JL, Peinado R, Gnoatto M, Arias MA, Gonzalez-Vasserot M, et al. Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia. Eur Heart J. 2006;27(1):89–95. PubMed Abello M, Merino JL, Peinado R, Gnoatto M, Arias MA, Gonzalez-Vasserot M, et al. Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia. Eur Heart J. 2006;27(1):89–95. PubMed
30.
Zurück zum Zitat Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol. 1995;26(1):180–4. PubMed Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol. 1995;26(1):180–4. PubMed
31.
Zurück zum Zitat Lerecouvreux M, Ait Said M, Paziaud O, Perrier E, Carlioz R, Lavergne T, et al. Automobile driving and implantable defibrillators. Arch Mal Coeur Vaiss. 2005;98:288–93. PubMed Lerecouvreux M, Ait Said M, Paziaud O, Perrier E, Carlioz R, Lavergne T, et al. Automobile driving and implantable defibrillators. Arch Mal Coeur Vaiss. 2005;98:288–93. PubMed
32.
Zurück zum Zitat Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001;345(6):391–7. PubMed Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001;345(6):391–7. PubMed
33.
Zurück zum Zitat Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, et al. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias. Results from the TOVA study. J Am Coll Cardiol. 2007;50(23:2233–40. Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, et al. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias. Results from the TOVA study. J Am Coll Cardiol. 2007;50(23:2233–40.
37.
Zurück zum Zitat Bleakley JF, Akiyama T. Driving and arrhythmias: implications of new data. Card Electrophysiol Rev. 2003;7(1):77–9. PubMed Bleakley JF, Akiyama T. Driving and arrhythmias: implications of new data. Card Electrophysiol Rev. 2003;7(1):77–9. PubMed
38.
Zurück zum Zitat Thijssen J, Borleffs CJW, Van Rees JB, De Bie MK, Van Der Velde ET, Van Erven L, et al. Driving restrictions after implantable cardioverter defibrillator implantation: An evidence-based approach. Eur Heart J. 2011;32(21):2678–87. PubMedPubMedCentral Thijssen J, Borleffs CJW, Van Rees JB, De Bie MK, Van Der Velde ET, Van Erven L, et al. Driving restrictions after implantable cardioverter defibrillator implantation: An evidence-based approach. Eur Heart J. 2011;32(21):2678–87. PubMedPubMedCentral
39.
Zurück zum Zitat Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933–40. PubMed Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933–40. PubMed
40.
Zurück zum Zitat Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 2002;337(22):1569–75. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 2002;337(22):1569–75.
41.
Zurück zum Zitat Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, et al. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014;25(1):52–9. PubMed Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, et al. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014;25(1):52–9. PubMed
42.
Zurück zum Zitat Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary heart disease. N Engl J Med. 1999;341(25):1882–90. PubMed Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary heart disease. N Engl J Med. 1999;341(25):1882–90. PubMed
43.
Zurück zum Zitat Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8. PubMed Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8. PubMed
44.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. PubMed Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. PubMed
45.
Zurück zum Zitat Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50. PubMed Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50. PubMed
46.
Zurück zum Zitat Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481–8. PubMed Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481–8. PubMed
47.
Zurück zum Zitat Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in Implantable Cardioverter-defibrillators reduces shocks in primary prevention patients. Results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol. 2008;52(7):541–50. PubMed Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in Implantable Cardioverter-defibrillators reduces shocks in primary prevention patients. Results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol. 2008;52(7):541–50. PubMed
48.
Zurück zum Zitat Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary preventi. Eur Heart J. 2009;30(22):2758–67. PubMedPubMedCentral Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary preventi. Eur Heart J. 2009;30(22):2758–67. PubMedPubMedCentral
49.
Zurück zum Zitat Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83. PubMed Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83. PubMed
50.
Zurück zum Zitat Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythmia. 2017;33(6):594–601. Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythmia. 2017;33(6):594–601.
51.
Zurück zum Zitat Conti JB, Woodard DA, Tucker KJ, Bryant B, King LC, Curtis AB. Modification of patient driving behavior after implantation of a cardioverter defibrillator. Pacing Clin Electrophysiol. 1997;20(9):2200–4. PubMed Conti JB, Woodard DA, Tucker KJ, Bryant B, King LC, Curtis AB. Modification of patient driving behavior after implantation of a cardioverter defibrillator. Pacing Clin Electrophysiol. 1997;20(9):2200–4. PubMed
52.
Zurück zum Zitat Raviele A, Gasparini G. Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients. Pacing Clin Electrophysiol. 1995;18(3):599–608. PubMed Raviele A, Gasparini G. Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients. Pacing Clin Electrophysiol. 1995;18(3):599–608. PubMed
53.
Zurück zum Zitat Epstein AE, Baker JH, Beau SL, Deering TF, Greenberg SM, Goldman DS. Performance of the St. Jude Medical Riata Leads. Heart Rhythm. 2009;6(2):204–9. PubMed Epstein AE, Baker JH, Beau SL, Deering TF, Greenberg SM, Goldman DS. Performance of the St. Jude Medical Riata Leads. Heart Rhythm. 2009;6(2):204–9. PubMed
54.
Zurück zum Zitat Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol. 1996;28(5):1278–82. PubMed Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol. 1996;28(5):1278–82. PubMed
55.
Zurück zum Zitat Simpson C, Dorian P, Gupta A, Hamilton R, Hoffmaster B, Klein G, et al. CCS Consensus Conference 2003: assessment of the cardiac patient for fitness to drive and fly—executive summary. Can J Cardiol. 2004;20(13):1314–20. PubMed Simpson C, Dorian P, Gupta A, Hamilton R, Hoffmaster B, Klein G, et al. CCS Consensus Conference 2003: assessment of the cardiac patient for fitness to drive and fly—executive summary. Can J Cardiol. 2004;20(13):1314–20. PubMed
56.
Zurück zum Zitat Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, et al. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J. 1994;12 7:1064–7. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, et al. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J. 1994;12 7:1064–7.
57.
Zurück zum Zitat Steinbach K, Merl O, Frohner K, Hief C, Nurnberg M, Kaltenbrunner W, et al. Hemodynamics during ventricular tachyarrhythmias. Am Heart J. 1994;127:1102–6. PubMed Steinbach K, Merl O, Frohner K, Hief C, Nurnberg M, Kaltenbrunner W, et al. Hemodynamics during ventricular tachyarrhythmias. Am Heart J. 1994;127:1102–6. PubMed
58.
Zurück zum Zitat Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, et al. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol. 2011;34(7):433–6. PubMedPubMedCentral Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, et al. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol. 2011;34(7):433–6. PubMedPubMedCentral
59.
Zurück zum Zitat Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–65. PubMed Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–65. PubMed
60.
Zurück zum Zitat Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122(23):2359–67. PubMed Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122(23):2359–67. PubMed
61.
Zurück zum Zitat van Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ, et al. Inappropriate implantable cardioverter-defibrillator shocks. J Am Coll Cardiol. 2011;57(5):556–62. PubMed van Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ, et al. Inappropriate implantable cardioverter-defibrillator shocks. J Am Coll Cardiol. 2011;57(5):556–62. PubMed
62.
Zurück zum Zitat Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110(25):3760–5. PubMed Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110(25):3760–5. PubMed
63.
Zurück zum Zitat Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10):1009–17. PubMedPubMedCentral Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10):1009–17. PubMedPubMedCentral
64.
Zurück zum Zitat Park KW, Kang SH, Kang HJ, Koo BK, Park BE, Cha KS, et al. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based zotarolimus-eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE noninferiority trial. J Am Coll Cardiol. 2014;63(25):2805–16. PubMed Park KW, Kang SH, Kang HJ, Koo BK, Park BE, Cha KS, et al. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based zotarolimus-eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE noninferiority trial. J Am Coll Cardiol. 2014;63(25):2805–16. PubMed
65.
Zurück zum Zitat Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, et al. A systematic review and meta-analysis of the association between Implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31:270–7. PubMed Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, et al. A systematic review and meta-analysis of the association between Implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31:270–7. PubMed
66.
Zurück zum Zitat Streitner F, Herrmann T, Kuschyk J, Lang S, Doesch C, Papavassiliu T, et al. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. Plos One. 2013;8(5):1–7. Streitner F, Herrmann T, Kuschyk J, Lang S, Doesch C, Papavassiliu T, et al. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. Plos One. 2013;8(5):1–7.
67.
Zurück zum Zitat Strickberger SA, Canby R, Cooper J, Coppess M, Doshi R, John R, et al. Association of antitachycardia pacing or shocks with survival in 69,000 patients with an implantable defibrillator. J Cardiovasc Electrophysiol. 2017;28(4):416–22. PubMed Strickberger SA, Canby R, Cooper J, Coppess M, Doshi R, John R, et al. Association of antitachycardia pacing or shocks with survival in 69,000 patients with an implantable defibrillator. J Cardiovasc Electrophysiol. 2017;28(4):416–22. PubMed
68.
Zurück zum Zitat Merchant FM, Hoskins MH, Benser ME, Roberts G, Bastek AN, Knezevic A, et al. Time course of subsequent shocks after initial implantable cardioverter-defibrillator discharge and implications for driving restrictions. JAMA Cardiol. 2016;1(2):181–8. PubMed Merchant FM, Hoskins MH, Benser ME, Roberts G, Bastek AN, Knezevic A, et al. Time course of subsequent shocks after initial implantable cardioverter-defibrillator discharge and implications for driving restrictions. JAMA Cardiol. 2016;1(2):181–8. PubMed
69.
Zurück zum Zitat Kim MH, Zhang Y, Sakaguchi S, Goldberger JJ. Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions. Heart Rhythm. 2015;12(8):1728–36. PubMed Kim MH, Zhang Y, Sakaguchi S, Goldberger JJ. Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions. Heart Rhythm. 2015;12(8):1728–36. PubMed
70.
Zurück zum Zitat Fröhlig G. Komplikationen der Defibrillatortherapie Herzschrittmacher- und Defibrillator-Therapie: Indikation – Programmierung – Nachsorge. Stuttgart, New York: Thieme; 2006. pp. 407–22. Fröhlig G. Komplikationen der Defibrillatortherapie Herzschrittmacher- und Defibrillator-Therapie: Indikation – Programmierung – Nachsorge. Stuttgart, New York: Thieme; 2006. pp. 407–22.
71.
Zurück zum Zitat Watanabe E, Okajima K, Shimane A, Ozawa T, Manaka T, Morishima I, et al. Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing. J Interv Card Electrophysiol. 2017;49(3):271–80. PubMedPubMedCentral Watanabe E, Okajima K, Shimane A, Ozawa T, Manaka T, Morishima I, et al. Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing. J Interv Card Electrophysiol. 2017;49(3):271–80. PubMedPubMedCentral
72.
Zurück zum Zitat Smith T. Driving after ventricular arrhythmias. N Engl J Med. 2001;345:451–2. PubMed Smith T. Driving after ventricular arrhythmias. N Engl J Med. 2001;345:451–2. PubMed
73.
Zurück zum Zitat Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2‑year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–15. PubMed Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2‑year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–15. PubMed
74.
Zurück zum Zitat Olde Nordkamp LRA, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS, et al. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163(5):753–60. PubMed Olde Nordkamp LRA, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS, et al. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163(5):753–60. PubMed
75.
Zurück zum Zitat Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018;138(13):e392–414. PubMed Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018;138(13):e392–414. PubMed
76.
Zurück zum Zitat Schwab JO, Bänsch D, Israel C, Nowak B. Stellungnahme zum Einsatz des tragbaren Kardioverter/Defibrillators. Kardiologe. 2015;9(2):165–70. Schwab JO, Bänsch D, Israel C, Nowak B. Stellungnahme zum Einsatz des tragbaren Kardioverter/Defibrillators. Kardiologe. 2015;9(2):165–70.
77.
Zurück zum Zitat Scherr D, Mörtl D, Keller H, Ebner C. Positionspapier zum Einsatz des tragbaren Kardioverter-Defibrillators // Wearable cardioverter-defibrillator—a review. Austrian J Cardiol. 2017;24(9/10):206–11. Scherr D, Mörtl D, Keller H, Ebner C. Positionspapier zum Einsatz des tragbaren Kardioverter-Defibrillators // Wearable cardioverter-defibrillator—a review. Austrian J Cardiol. 2017;24(9/10):206–11.
78.
Zurück zum Zitat Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, et al. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace. 2017;19(3):335–45. PubMed Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, et al. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace. 2017;19(3):335–45. PubMed
79.
Zurück zum Zitat Reek S, Geller JC, Meltendorf U, Wollbrueck A, Szymkiewicz SJ, Klein HU. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol. 2003;26(10):2016–22. PubMed Reek S, Geller JC, Meltendorf U, Wollbrueck A, Szymkiewicz SJ, Klein HU. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol. 2003;26(10):2016–22. PubMed
80.
Zurück zum Zitat Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353–67. PubMed Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353–67. PubMed
81.
Zurück zum Zitat Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27(1):4–9. PubMed Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27(1):4–9. PubMed
82.
Zurück zum Zitat Sharma PS, Bordachar P, Ellenbogen KA. Indications and use of the wearable cardiac defibrillator. Eur Heart J. 2017;38(4):258–67. PubMed Sharma PS, Bordachar P, Ellenbogen KA. Indications and use of the wearable cardiac defibrillator. Eur Heart J. 2017;38(4):258–67. PubMed
83.
Zurück zum Zitat Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. 2015;132(17):1613–9. PubMed Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. 2015;132(17):1613–9. PubMed
84.
Zurück zum Zitat Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62(21):2000–7. PubMed Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62(21):2000–7. PubMed
85.
Zurück zum Zitat Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56(3):194–203. PubMedPubMedCentral Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56(3):194–203. PubMedPubMedCentral
86.
Zurück zum Zitat Ponikowski P, Voors A. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC): developed with the special contribution. Russ J Cardiol. 2017;141:7–81. Ponikowski P, Voors A. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC): developed with the special contribution. Russ J Cardiol. 2017;141:7–81.
87.
Zurück zum Zitat Wäßnig NK, Günther M, Quick S, Pfluecke C, Rottstädt F, Szymkiewicz SJ, et al. Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation. 2016;134(9):635–43. PubMedPubMedCentral Wäßnig NK, Günther M, Quick S, Pfluecke C, Rottstädt F, Szymkiewicz SJ, et al. Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation. 2016;134(9):635–43. PubMedPubMedCentral
88.
Zurück zum Zitat Odeneg T, Ebner C, Mortl D. Indications for and outcome in patients with the wearable cardioverter defibrillator (WCD)—results of the austrian WCD registry. Wien Klin Wochenschr. 2016;128:229. Odeneg T, Ebner C, Mortl D. Indications for and outcome in patients with the wearable cardioverter defibrillator (WCD)—results of the austrian WCD registry. Wien Klin Wochenschr. 2016;128:229.
89.
Zurück zum Zitat Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, et al. Wearable cardioverter–defibrillator after myocardial infarction. N Engl J Med. 2018;379(13):1205–15. PubMedPubMedCentral Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, et al. Wearable cardioverter–defibrillator after myocardial infarction. N Engl J Med. 2018;379(13):1205–15. PubMedPubMedCentral
90.
Zurück zum Zitat Niwano S, Sekiguchi Y, Ishii Y, Iwasaki Y, Kato R, Okamura H, et al. Clinical usefulness of wearable cardioverter defibrillator (WCD) and current understanding of its clinical indication in Japan. Circ J. 2018;82(6):1481–6. PubMed Niwano S, Sekiguchi Y, Ishii Y, Iwasaki Y, Kato R, Okamura H, et al. Clinical usefulness of wearable cardioverter defibrillator (WCD) and current understanding of its clinical indication in Japan. Circ J. 2018;82(6):1481–6. PubMed
91.
Zurück zum Zitat Johansson I, Strömberg A. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator—the patient perspective. J Cardiovasc Nurs. 2010;25(6):E1–10. PubMed Johansson I, Strömberg A. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator—the patient perspective. J Cardiovasc Nurs. 2010;25(6):E1–10. PubMed
92.
Zurück zum Zitat Eckert M, Jones T. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families? Int J Nurs Pract. 2002;8(3):152–7. PubMed Eckert M, Jones T. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families? Int J Nurs Pract. 2002;8(3):152–7. PubMed
93.
Zurück zum Zitat Timmermans I, Jongejan N, Meine M, Doevendans P, Tuinenburg A, Versteeg H. Decreased quality of life due to driving restrictions after cardioverter defibrillator implantation. J Cardiovasc Nurs. 2018;33(5):474–80. PubMed Timmermans I, Jongejan N, Meine M, Doevendans P, Tuinenburg A, Versteeg H. Decreased quality of life due to driving restrictions after cardioverter defibrillator implantation. J Cardiovasc Nurs. 2018;33(5):474–80. PubMed
94.
Zurück zum Zitat Hickey K, Curtis AB, Lancaster S, Larsen G, Warwick D, McAnulty J, et al. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. Am Heart J. 2001;142(1):99–104. PubMed Hickey K, Curtis AB, Lancaster S, Larsen G, Warwick D, McAnulty J, et al. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. Am Heart J. 2001;142(1):99–104. PubMed
95.
Zurück zum Zitat Mylotte D, Sheahan RG, Nolan PG, Neylon MA, McArdle B, Constant O, et al. The implantable defibrillator and return to operation of vehicles study. Europace. 2013;15(2):212–8. PubMed Mylotte D, Sheahan RG, Nolan PG, Neylon MA, McArdle B, Constant O, et al. The implantable defibrillator and return to operation of vehicles study. Europace. 2013;15(2):212–8. PubMed
96.
Zurück zum Zitat Bjerre J, Rosenkranz SH, Christensen AM, Schou M, Jøns C, Gislason G, et al. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire. BMC Cardiovasc Disord. 2018;18(1):212. PubMedPubMedCentral Bjerre J, Rosenkranz SH, Christensen AM, Schou M, Jøns C, Gislason G, et al. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire. BMC Cardiovasc Disord. 2018;18(1):212. PubMedPubMedCentral
97.
Zurück zum Zitat Dicarlo LA, Winston SA, Honoway S, Reed P. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws. Pacing Clin Electrophysiol. 1992;15:1131–6. PubMed Dicarlo LA, Winston SA, Honoway S, Reed P. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws. Pacing Clin Electrophysiol. 1992;15:1131–6. PubMed
98.
Zurück zum Zitat Jongejan N, Timmermans I, Elders J, Meijer K, Meine M, Doevendans PA, et al. Driving restrictions for Dutch patients with an implantable cardioverter defibrillator compliance and associated factors. Neth Heart J. 2018;26(2):69–75. PubMed Jongejan N, Timmermans I, Elders J, Meijer K, Meine M, Doevendans PA, et al. Driving restrictions for Dutch patients with an implantable cardioverter defibrillator compliance and associated factors. Neth Heart J. 2018;26(2):69–75. PubMed
100.
Zurück zum Zitat Mârgulescu AD, Anderson MH. A review of driving restrictions in patients at risk of syncope and cardiac arrhythmias associated with sudden incapacity: differing global approaches to regulation and risk. Arrhythmia Electrophysiol Rev. 2019;8(2):90–98. Mârgulescu AD, Anderson MH. A review of driving restrictions in patients at risk of syncope and cardiac arrhythmias associated with sudden incapacity: differing global approaches to regulation and risk. Arrhythmia Electrophysiol Rev. 2019;8(2):90–98.
101.
Zurück zum Zitat Van Erven L, Schalij MJ. Troubleshooting implantable cardioverter-defibrillator related problems. Heart. 2008;94(5):649–60. PubMed Van Erven L, Schalij MJ. Troubleshooting implantable cardioverter-defibrillator related problems. Heart. 2008;94(5):649–60. PubMed
102.
Zurück zum Zitat Wilkoff BL, Fauchier L, Stiles MK, Aguinaga L, Morillo CA, Al-khatib SM, et al. Corrigendum to: 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing (Europace (2016) 2 (159–183)). Europace. 2017;19(4):580. Wilkoff BL, Fauchier L, Stiles MK, Aguinaga L, Morillo CA, Al-khatib SM, et al. Corrigendum to: 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing (Europace (2016) 2 (159–183)). Europace. 2017;19(4):580.
103.
Zurück zum Zitat Abboud J, Ehrlich J. Antiarrhythmic drug therapy to avoid Implantable cardioverter defibrillator shocks. Arrhythmia Electrophysiol Rev. 2016;5(2):117. Abboud J, Ehrlich J. Antiarrhythmic drug therapy to avoid Implantable cardioverter defibrillator shocks. Arrhythmia Electrophysiol Rev. 2016;5(2):117.
106.
Zurück zum Zitat Burger AL, Stojkovic S, Schmidinger H, Ristl R, Pezawas T. Defensive implantable cardioverter-defibrillator programming is safe and reduces inappropriate therapy—comparison of 3 programming strategies in 1,471 patients. Circ J. 2018;82(12):2976–82. PubMed Burger AL, Stojkovic S, Schmidinger H, Ristl R, Pezawas T. Defensive implantable cardioverter-defibrillator programming is safe and reduces inappropriate therapy—comparison of 3 programming strategies in 1,471 patients. Circ J. 2018;82(12):2976–82. PubMed
Metadaten
Titel
Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator
Different viewpoints around the world
verfasst von
M.D. Mona Cooper
M.D. Theresa Berent
Prim. Univ. Prof. Dr. Johann Auer
Prim. PD Dr. Robert Berent
Publikationsdatum
20.05.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-020-01675-0